Dr. Gemma Salvadó has been appointed new Group Leader of the Neuroimaging Research Group from our research center, the Barcelonaβeta Brain Research Center (BBRC). Salvadó holds a PhD in Biomedicine from the University of Barcelona and a Master's degree in Biomedical Engineering from the Polytechnic University of Catalonia. She has a solid track record in the field of neuroimaging, since she joined the BBRC Neuroimaging group as a predoctoral researcher in 2017, where she collaborated until 2021. During this stage, she carried out his doctoral thesis “Detection of early cerebral amyloid-ß deposition by PET imaging and its downstream effects”, focused on understanding the preclinical stages of Alzheimer's disease through the use of neuroimaging and fluid biomarkers. Her work was awarded in the II Edition of the National Prize as Best PhD Thesis in Image-Based Diagnosis and Genomics by the QUAES Foundation.
Dr. Salvadó has continued her research at Lund University (Sweden) as a research associate, where she will continue to collaborate to enrich her current work and where she has studied plasma and cerebrospinal fluid biomarkers to better understand the progression of the disease.
The BBRC Neuroimaging Research Group is a multidisciplinary team of experts in the acquisition, processing and analysis of complex neuroimaging data. Their research focuses primarily on the study of brain images obtained with magnetic resonance imaging (MRI) and positron emission tomography (PET), techniques that allow the identification of pathophysiological changes associated with Alzheimer's disease and healthy aging, offering valuable information for the development of prevention strategies.
Dr. Salvadó will fully incorporate herself into her new responsibility next january, but since November of this year it has already begun a progressive integration into the BBRC to facilitate a smooth transition.
